Fluid bolus therapy in pediatric sepsis: a narrative review

Eur J Med Res. 2022 Nov 12;27(1):246. doi: 10.1186/s40001-022-00885-8.


Leading cause of death in children under five, pediatric sepsis remains a significant global health threat. The 2020 Surviving Sepsis Campaign guidelines revised the management of septic shock and sepsis-associated organ dysfunction in children. In addition to empiric broad-spectrum antibiotics, fluid bolus therapy is one of the cornerstones of management, due to theoretical improvement of cardiac output, oxygen delivery and organ perfusion. Despite a very low level of evidence, the possible benefit of balanced crystalloids in sepsis resuscitation has led to discussion on their position as the ideal fluid. However, the latest adult data are not consistent with this, and the debate is still ongoing in pediatrics. We provide here the current state of knowledge on fluid bolus therapy in pediatric sepsis with emphasis on balanced crystalloids.

Keywords: Balanced crystalloids; Children; Fluid bolus therapy; Pediatric sepsis; Surviving sepsis campaign.

Publication types

  • Review

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Fluid Therapy
  • Humans
  • Resuscitation
  • Sepsis* / therapy
  • Shock, Septic* / therapy


  • Anti-Bacterial Agents